BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Lu Z, Chang L, Zhou H, Liu X, Li Y, Mi T, Tong D. Arctigenin Attenuates Tumor Metastasis Through Inhibiting Epithelial-Mesenchymal Transition in Hepatocellular Carcinoma via Suppressing GSK3β-Dependent Wnt/β-Catenin Signaling Pathway In Vivo and In Vitro. Front Pharmacol 2019;10:937. [PMID: 31555129 DOI: 10.3389/fphar.2019.00937] [Cited by in Crossref: 7] [Cited by in F6Publishing: 14] [Article Influence: 2.3] [Reference Citation Analysis]
Number Citing Articles
1 Chen YF, Liu RZ, Ying WW, Yang YN, Xiang SF, Shao XJ, Cao J, Zhang YQ, Yang B, He QJ, Ying MD. Arctigenin impairs UBC12 enzyme activity and cullin neddylation to attenuate cancer cells. Acta Pharmacol Sin 2022. [PMID: 36138144 DOI: 10.1038/s41401-022-00992-6] [Reference Citation Analysis]
2 Shokouhian B, Aboulkheyr Es H, Negahdari B, Tamimi A, Shahdoust M, Shpichka A, Timashev P, Hassan M, Vosough M. Hepatogenesis and hepatocarcinogenesis: Alignment of the main signaling pathways. J Cell Physiol 2022. [PMID: 36037302 DOI: 10.1002/jcp.30862] [Reference Citation Analysis]
3 Hassan ESE, Shafaa MW, Faraag AHI, Essawy E, Bakkar AA, Al-Megrin WA, El-Khadragy MF, Abdelfattah MS, Abdel Moneim AE. Evaluation of the antineoplastic property of prodigiosins and 5-fluorouracil in restraining the growth of Ehrlich solid tumors in mice. Environ Sci Pollut Res Int 2022. [PMID: 35773616 DOI: 10.1007/s11356-022-21678-w] [Reference Citation Analysis]
4 Deldar Abad Paskeh M, Mirzaei S, Ashrafizadeh M, Zarrabi A, Sethi G. Wnt/β-Catenin Signaling as a Driver of Hepatocellular Carcinoma Progression: An Emphasis on Molecular Pathways. J Hepatocell Carcinoma 2021;8:1415-44. [PMID: 34858888 DOI: 10.2147/JHC.S336858] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
5 Rečnik LM, Thatcher RJ, Mallah S, Butts CP, Collingridge GL, Molnár E, Jane DE, Willis CL. Synthesis and pharmacological characterisation of arctigenin analogues as antagonists of AMPA and kainate receptors. Org Biomol Chem 2021;19:9154-62. [PMID: 34642722 DOI: 10.1039/d1ob01653a] [Reference Citation Analysis]
6 Janthamala S, Jusakul A, Kongpetch S, Kimawaha P, Klanrit P, Loilome W, Namwat N, Techasen A. Arctigenin inhibits cholangiocarcinoma progression by regulating cell migration and cell viability via the N-cadherin and apoptosis pathway. Naunyn Schmiedebergs Arch Pharmacol 2021. [PMID: 34283274 DOI: 10.1007/s00210-021-02123-0] [Reference Citation Analysis]
7 Zhang LY, Zhang JG, Yang X, Cai MH, Zhang CW, Hu ZM. Targeting Tumor Immunosuppressive Microenvironment for the Prevention of Hepatic Cancer: Applications of Traditional Chinese Medicines in Targeted Delivery. Curr Top Med Chem 2020;20:2789-800. [PMID: 33076809 DOI: 10.2174/1568026620666201019111524] [Reference Citation Analysis]
8 Mottaghi S, Abbaszadeh H. A comprehensive mechanistic insight into the dietary and estrogenic lignans, arctigenin and sesamin as potential anticarcinogenic and anticancer agents. Current status, challenges, and future perspectives. Crit Rev Food Sci Nutr 2021;:1-17. [PMID: 33905270 DOI: 10.1080/10408398.2021.1913568] [Reference Citation Analysis]
9 Luo W, Wang F, Luo H, Liu H. Arctigenin inhibits human breast cancer cell proliferation, migratory and invasive abilities and epithelial to mesenchymal transition by targeting 4EBP1. Exp Ther Med 2021;21:547. [PMID: 33850519 DOI: 10.3892/etm.2021.9979] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
10 Jiang Y, Liu J, Hong W, Fei X, Liu R. Arctigenin Inhibits Glioblastoma Proliferation through the AKT/mTOR Pathway and Induces Autophagy. Biomed Res Int 2020;2020:3542613. [PMID: 33015162 DOI: 10.1155/2020/3542613] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
11 Shi H, Zhao L, Guo X, Fang R, Zhang H, Dong G, Fu J, Yan F, Zhang J, Ning Z, Ma Q, Li Z, Li C, Dai J, Si C, Xiong H. Arctigenin Attenuates Breast Cancer Progression through Decreasing GM-CSF/TSLP/STAT3/β-Catenin Signaling. Int J Mol Sci 2020;21:E6357. [PMID: 32887217 DOI: 10.3390/ijms21176357] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
12 Niu ZS, Wang WH, Dong XN, Tian LML. Role of long noncoding RNA-mediated competing endogenous RNA regulatory network in hepatocellular carcinoma. World J Gastroenterol 2020; 26(29): 4240-4260 [PMID: 32848331 DOI: 10.3748/wjg.v26.i29.4240] [Cited by in CrossRef: 18] [Cited by in F6Publishing: 19] [Article Influence: 9.0] [Reference Citation Analysis]
13 Wang J, Wang Y, Zhang H, Chang J, Lu M, Gao W, Liu W, Li Y, Yin L, Wang X, Wang Y, Gao M, Yin Z. Identification of a novel microRNA-141-3p/Forkhead box C1/β-catenin axis associated with rheumatoid arthritis synovial fibroblast function in vivo and in vitro. Theranostics 2020;10:5412-34. [PMID: 32373221 DOI: 10.7150/thno.45214] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 6.5] [Reference Citation Analysis]
14 Guo S, Chen Y, Shi S, Wang X, Zhang H, Zhan Y, An H. Arctigenin, a novel TMEM16A inhibitor for lung adenocarcinoma therapy. Pharmacol Res 2020;155:104721. [PMID: 32097750 DOI: 10.1016/j.phrs.2020.104721] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 4.5] [Reference Citation Analysis]